MoneyWorks4Me

The sales declined to Rs. 656.35 millions for the June 2025 quarter as compared to Rs. 731.27 millions during the corresponding quarter last year.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 3.24  millions as against Rs. 3.58 millions reported during the corresponding quarter ended.OP of the company witnessed a marginal growth to 68.95 millions from 68.48 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 656.35 731.27 -10.25 656.35 731.27 -10.25 3024.96 3385.40 -10.65
Other Income 7.41 2.85 160.00 7.41 2.85 160.00 21.49 23.03 -6.69
PBIDT 68.95 68.48 0.69 68.95 68.48 0.69 322.26 338.29 -4.74
Interest 40.52 37.06 9.34 40.52 37.06 9.34 168.45 144.61 16.49
PBDT 28.43 31.42 -9.52 28.43 31.42 -9.52 153.81 193.68 -20.59
Depreciation 25.19 24.26 3.83 25.19 24.26 3.83 96.49 100.49 -3.98
PBT 3.24 7.16 -54.75 3.24 7.16 -54.75 57.32 93.19 -38.49
TAX 0.00 3.58 0.00 0.00 3.58 0.00 -20.67 15.94 -229.67
Deferred Tax 0.00 -1.90 0.00 0.00 -1.90 0.00 -19.27 8.38 -329.95
PAT 3.24 3.58 -9.50 3.24 3.58 -9.50 77.99 77.25 0.96
Equity 159.21 158.04 0.74 159.21 158.04 0.74 159.21 158.04 0.74
PBIDTM(%) 10.51 9.36 12.18 10.51 9.36 12.18 10.65 9.99 6.61
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..